Real World Evidence (RWE) Solutions Market - Trends Forecast Till 2028

Real World Evidence (RWE) Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Neurology), End User (Pharma, Medtech, Payers, Providers) and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-HC-RWESM-527

Format:  

Number of Pages: 421

Domain: Healthcare

Real World Evidence (RWE) Solutions Market – Trends Forecast Till 2028

The Real-World Evidence (RWE) Solutions market size is projected to reach a CAGR of 14.6% from 2021 to 2028.

Real World Evidence (RWE) are the evidence which are collected by the experiments or trials conducted on random population but are in a controlled manner. These are usually performed during the routine clinical practice. The potential benefits or risks of a medicinal products which is deduced by the analysis of collected evidence.

With a higher number of geriatric population and the recent shift from a volume- to value-based care are some of the factors that have supported long-term expansion for Real World Evidence (RWE) Solutions Market.

COVID-19 had a positive effect on the market, as it became the most commonly used and influential technology to deal with the pandemic as it provides a better alternative and understanding of the pandemic.

Real World Evidence (RWE) Solutions Market Growth Analysis

North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the increased R&D in the sector and the favourable governmental policies.

Real World Evidence (RWE) Solutions Market is segmented into Component, Therapeutic Area and End User and region.

On the basis of Component

  • Services
  • Data Sets
  • Clinical setting data
  • Claims data
  • Pharmacy data
  • Patient powered data

On the basis of Therapeutic Area

  • Oncology
  • Cardiovascular
  • Neurology
  • Immunology
  • Others

On the basis of End-User

  • Pharmaceutical and Medical Devices Companies
  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Real World Evidence (RWE) Solutions Market Primary Respondent

 

Key Players

  • IQVIA
  • IBM Corporation
  • ICON plc.
  • PAREXEL International Corporation
  • PPD
  • LLC
  • Optum, Inc.
  • Cognizant Technology Solutions Corporation
  • Oracle Corporation
  • SAS Institute Inc.
  • Syneos Health, Inc.
  • Anthem, Inc.
  • Clinigen Group plc.
  • Medpace Holdings Inc. 
  • Flatiron Health, Inc.

Recent Developments

  • In May 2021, Verantos signed up a partnership with Lundbeck with an aim of extensive study to enable RWE in support of migraine therapy.
  • In May 2021, Five organizations entered into an industry coalition which are Aetion, Flatiron Health, IQVIA, Syapse, and Tempus.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Real World Evidence (RWE) Solutions Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Growth Rate

CAGR of 14.6% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Component, Therapeutic Area and End User and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

IQVIA , IBM Corporation , ICON plc. , PAREXEL International Corporation , PPD, LLC , Optum, Inc. , Cognizant Technology Solutions Corporation , Oracle Corporation , SAS Institute Inc. , Syneos Health, Inc. , Anthem, Inc. , Clinigen Group plc. , Medpace Holdings Inc.  and Flatiron Health, Inc.

Available Customization

In addition to the market data for Real World Evidence (RWE) Solutions Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.